Merck’S Cancer (Melanoma) Immunotherapy Drug may Get FDA approval

August 25, 2014 5:27 PM

6 0

Merck’S Cancer (Melanoma) Immunotherapy Drug may Get FDA approval

Highly anticipated immuno-oncology drug, pembrolizumab, which has shown promising results in trials as a treatment for Melanoma could be approved by the US FDA. The drug is a product from Merck & Co’s, and is being hailed as a treatment for melanoma.

If the drug is approved it will become the first from a promising class of drug which have been designed to fend off cancer by blocking a protein Programmed Death receptor (PD-1), or a related target known as PD-L1, used by tumors to dodge disease-fighting cells.

Read more

To category page

Loading...